Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology · CDKL5 Deficiency Disorder

Understanding a CDKL5 Deficiency Disorder Diagnosis

At a Glance

A CDKL5 deficiency disorder diagnosis means a disease-causing change in the CDKL5 gene affects brain development and often causes seizures in infancy. Children may also have differences in movement, vision, communication, sleep, and digestion, and each child’s developmental path is different.

Receiving a diagnosis of CDKL5 Deficiency Disorder (CDD) often brings a complex wave of emotions. For many parents, it is a moment of profound grief and fear for the future, while for others, it provides a long-sought explanation for a child’s medical struggles [1]. Whatever you are feeling—shock, relief, or overwhelm—is a valid response to this life-altering information.

CDD is a rare genetic condition, occurring in approximately 1 in 40,000 to 60,000 live births [2][3]. It is caused by a pathogenic variant (a change known to cause disease) in the CDKL5 gene, which provides instructions for making a protein essential for normal brain development and function [2]. Because this gene is located on the X chromosome, the disorder is considered X-linked, meaning it typically affects females more often than males, though it can occur in both [4][5]. Most CDKL5 variants are de novo, meaning they occurred spontaneously and were not inherited, but it is highly recommended to meet with a genetic counselor and undergo parental testing to establish recurrence risk. If you see a “variant of uncertain significance,” this alone does not establish a CDD diagnosis without further clinical correlation.

Beyond Epilepsy: A Multisystem Disorder

One of the most important things to understand is that CDD is not just an epilepsy syndrome. It is classified as a developmental and epileptic encephalopathy (DEE) [2].

  • Developmental Encephalopathy: This refers to the fact that the genetic change itself impacts how the brain develops from the start, causing developmental impairment independent of seizure activity [6].
  • Epileptic Encephalopathy: This means that frequent, intense seizure activity (and the abnormal brain waves between seizures) can further interfere with a child’s ability to learn and reach milestones [2][6].

While seizures are often the first and most visible symptom—usually starting in the first few months of life—CDD is a lifelong, multisystem disorder [2][7]. Research confirms that it affects many parts of the body and daily life, including:

  • Motor Skills: Many children experience low muscle tone (hypotonia) and significant delays in sitting, standing, and walking [8][9].
  • Vision: Approximately 75% of children with CDD have Cortical Visual Impairment (CVI), where the brain has difficulty processing what the eyes see [10].
  • Gastrointestinal Health: Issues like severe constipation and reflux are very common [7].
  • Sleep: Persistent sleep disturbances, including difficulty falling or staying asleep, affect both the child and the caregiver’s quality of life [11].

Navigating the Unknowns

It is natural to want a clear “roadmap” for your child’s future. However, one of the most challenging aspects of CDD is its variability. While scientists have identified certain patterns—for example, some specific genetic variants may be associated with a higher likelihood of walking—the exact developmental trajectory for any individual child remains uncertain [8][12].

  • Communication: While many children with CDD do not use spoken words, research shows they often communicate intentionally through facial expressions, body movements, and other non-verbal modes [13].
  • The “Honeymoon” Period: Some children experience a temporary break from seizures, sometimes lasting weeks or months, before they return [10][8]. For instance, one observational study noted that 43% of patients had a seizure-free period, but 94% eventually saw their seizures return [10]. This observational statistic doesn’t predict your child’s exact future, but it is important to know so that you never stop or change a medication on your own during a seizure-free period.
  • Lifelong Progress: Development in CDD is typically slow and may not follow a standard timeline, but children can continue to make gains in communication and motor skills throughout their lives [14][13].

Building a Support System

Because CDD impacts so many areas of health, care is most effective when it is holistic and multidisciplinary [2]. Your team will likely include neurologists, gastroenterologists, physical and occupational therapists, and vision specialists [15].

As you navigate this journey, remember that your child’s diagnosis is only one part of their story. While the medical literature describes the challenges, it cannot capture your child’s unique personality or the deep bond you will continue to build. Focus on small victories and seek out the CDD community, where shared experiences can provide the understanding and hope that data alone cannot.

For information on managing emergency situations and recognizing when to seek urgent care, please refer to the emergency care page.

Common questions in this guide

What causes CDKL5 deficiency disorder?
CDKL5 deficiency disorder is caused by a disease-causing change in the CDKL5 gene, which is important for brain development and function. Most changes happen spontaneously rather than being inherited, but genetic counseling and testing for both parents can help clarify the chance of it occurring in another pregnancy. A variant of uncertain significance alone does not confirm the diagnosis.
Is CDKL5 deficiency disorder more than an epilepsy condition?
Yes. It affects brain development from the beginning, so developmental challenges are not caused only by seizures. Seizures and abnormal brain activity can add to learning and developmental difficulties, which is why the condition is described as a developmental and epileptic encephalopathy.
What symptoms can occur besides seizures?
Children with CDKL5 deficiency disorder may have low muscle tone, delayed motor skills, difficulty processing visual information, constipation, reflux, sleep problems, and limited spoken language. The combination and severity of these features vary from child to child.
Will my child with CDKL5 deficiency disorder learn to walk or talk?
Developmental outcomes vary widely, and an individual genetic variant cannot predict a child’s future with certainty. Many children do not use spoken words, but they may communicate intentionally through facial expressions, movements, eye gaze, or communication devices. Children can continue gaining communication and motor skills throughout life.
Can seizures stop for a while and then return in CDKL5 deficiency disorder?
Some children have a temporary seizure-free period lasting weeks or months, but seizures may return later. This pattern does not predict exactly what will happen for one child. Never stop or change seizure medicine without guidance from the child’s medical team.
Which specialists may help care for a child with CDKL5 deficiency disorder?
Care commonly involves a neurologist along with specialists who address digestion, movement, vision, and communication. Depending on the child’s needs, the team may include a gastroenterologist, physical and occupational therapists, a vision specialist, and a speech-language pathologist. A genetic counselor can help the family understand test results and recurrence risk.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific type of CDKL5 variant does my child have, and does it provide any initial clues about their potential developmental path?
  2. 2.What is the difference between my child's seizures and the 'encephalopathy' part of their diagnosis?
  3. 3.Who are the key specialists we need on our child's multidisciplinary team to manage the non-seizure aspects of CDD?
  4. 4.How do you evaluate for Cortical Visual Impairment (CVI), and what resources are available to help my child use their vision more effectively?
  5. 5.What are the 'honeymoon periods' we might see with seizures, and how should we manage our expectations during those times?
  6. 6.How can we work with a speech-language pathologist to explore non-verbal communication methods (like eye-gaze or switches) early on?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    The Lived Experience of Parents' Receiving the Diagnosis of CDKL5 Deficiency Disorder for Their Child.

    Demarest S, Marsh R, Treat L, et al.

    Journal of child neurology 2022; (37(6)):451-460 doi:10.1177/08830738221076285.

    PMID: 35196159
  2. 2

    International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

    Amin S, Monaghan M, Aledo-Serrano A, et al.

    Frontiers in neurology 2022; (13()):874695 doi:10.3389/fneur.2022.874695.

    PMID: 35795799
  3. 3

    Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.

    Katayama S, Sueyoshi N, Inazu T, Kameshita I

    Neural plasticity 2020; (2020()):6970190 doi:10.1155/2020/6970190.

    PMID: 32587608
  4. 4

    CDKL5 deficiency disorder in males: Five new variants and review of the literature.

    Siri B, Varesio C, Freri E, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2021; (33()):9-20 doi:10.1016/j.ejpn.2021.04.007.

    PMID: 33989939
  5. 5

    Clinical and Evolutionary Aspects of CDKL5-Related Developmental Epileptic Encephalopathy: A Case Report.

    Setouani S, Khabbach K, Lamzouri A, et al.

    Cureus 2026; (18(5)):e108475 doi:10.7759/cureus.108475.

    PMID: 42261526
  6. 6

    CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.

    Van Bergen NJ, Massey S, Quigley A, et al.

    Biochemical Society transactions 2022; (50(4)):1207-1224 doi:10.1042/BST20220791.

    PMID: 35997111
  7. 7

    The natural history of CDKL5 deficiency disorder into adulthood.

    Aledo-Serrano A, Lewis-Smith D, Leonard H, et al.

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.01.12.24318239.

    PMID: 39867409
  8. 8

    Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.

    Wong K, Junaid M, Demarest S, et al.

    European journal of human genetics : EJHG 2023; (31(2)):169-178 doi:10.1038/s41431-022-01163-1.

    PMID: 35978140
  9. 9

    CDKL5 deficiency disorder and other infantile-onset genetic epilepsies.

    Daniels C, Greene C, Smith L, et al.

    Developmental medicine and child neurology 2024; (66(4)):456-468 doi:10.1111/dmcn.15747.

    PMID: 37771170
  10. 10

    CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.

    Demarest ST, Olson HE, Moss A, et al.

    Epilepsia 2019; (60(8)):1733-1742 doi:10.1111/epi.16285.

    PMID: 31313283
  11. 11

    Long time polysomnographic sleep and breathing evaluations in children with CDKL5 deficiency disorder.

    Hagebeuk EEO, Smits A, de Weerd A

    Sleep medicine 2023; (103()):173-179 doi:10.1016/j.sleep.2023.02.003.

    PMID: 36812861
  12. 12

    Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.

    MacKay CI, Wong K, Demarest ST, et al.

    Clinical genetics 2021; (99(1)):157-165 doi:10.1111/cge.13862.

    PMID: 33047306
  13. 13

    Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: A descriptive qualitative study.

    Keeley J, Benson-Goldberg S, Saldaris J, et al.

    American journal of medical genetics. Part A 2024; (194(7)):e63570 doi:10.1002/ajmg.a.63570.

    PMID: 38425131
  14. 14

    Baseline characteristics and feasibility of clinical outcome measures in CDKL5 deficiency disorder: The CANDID observational study.

    Liogier d'Ardhuy X, , Cimms T, et al.

    Epilepsia 2026; (67(4)):1703-1721 doi:10.1002/epi.70095.

    PMID: 41531035
  15. 15

    Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.

    Amin S, Møller RS, Aledo-Serrano A, et al.

    Epilepsia open 2024; (9(3)):832-849 doi:10.1002/epi4.12914.

    PMID: 38450883

This page explains what a CDKL5 deficiency disorder diagnosis may involve for educational purposes and does not replace medical advice. Discuss your child’s genetic results, seizures, development, and care plan with their clinicians and genetic counselor.

Get notified when new evidence is published on CDKL5-deficiency disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.